granted
on 30 Nov 2023
Last Applicant/ Owned by
20 ACORN PARK DRIVE
CAMBRIDGE
MA
02140
Serial Number
90206856 filed on 24th Sep 2020
Registration Number
N/A
Correspondent Address
Christina M. Licursi
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Research and development in the field of computational biology, biotechnology and pharmaceuticals The English translation of "SENDA" in the mark is "path". Therapeutic preparations to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; pharmaceutical agents that modulate metabolism for scientific and research use; therapeutic pharmaceuticals for the treatment of dRead More
Research and development in the field of computational biology, biotechnology and pharmaceuticals
Therapeutic preparations to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; pharmaceutical agents that modulate metabolism for scientific and research use; therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism
No 90206856
No Service Mark
No V03132000700
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 02th Dec 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 30th Nov 2023 | SOU TEAS EXTENSION RECEIVED |
| 30th Nov 2023 | SOU EXTENSION 4 FILED |
| 30th Nov 2023 | SOU EXTENSION 4 GRANTED |
| 29th Apr 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 27th Apr 2023 | SOU TEAS EXTENSION RECEIVED |
| 27th Apr 2023 | SOU EXTENSION 3 FILED |
| 27th Apr 2023 | SOU EXTENSION 3 GRANTED |
| 14th Dec 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 12th Dec 2022 | SOU TEAS EXTENSION RECEIVED |
